Argá Medtech SA is a privately-held medical device company based in Switzerland founded by seasoned team of leaders in the industry. Argá is developing an innovative non-thermal energy based cardiac ablation system for the treatment of cardiac arrhythmias. With the use of Pulsed Electrical Fields (PEF) to create irreversible electroporation (IRE) of cardiomyocytes, Argá is developing a safer, faster, cheaper and more effective cardiac ablation treatment for the benefit of millions of people affected by cardiac rhythm disorders and atrial fibrillation.
Location: Switzerland, Vaud, Epalinges
Employees: 11-50
Total raised: $58.61M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 05.03.2021 | Earlybird ... | earlybird.... |
| - | Advent Lif... | adventls.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.03.2024 | Series B | $58.61M | - |
Mentions in press and media 10
| Date | Title | Description |
| 12.02.2026 | From trials to market: medtechs advance clinical programs | Founded in the Canton of Vaud in 2015, Aspivix developed carevix, a soft-suction cervical device designed as a modern, gentler alternative to the cervical tenaculum. The company has announced the publication of a multicentre post-marketing... |
| 04.03.2024 | Argá Medtech Secures €54M in Series B Funding | Argá Medtech, a Swiss company specializing in cardiac ablation systems, recently closed a successful €54 million Series B funding round. The funding was oversubscribed, demonstrating strong investor interest in the company's innovative tech... |
| 04.03.2024 | Argá Medtech secures €54 million in oversubscribed series B | Argá Medtech’s CSE ablation system enables electrophysiologists to treat any region in the heart safely and efficiently using a single, multi-configurable catheter while titrating lesion depths according to the location within the heart. T... |
| 03.03.2024 | Argá Medtech Closes €54M Series B Funding | Argá Medtech, a Lausanne, Switzerland-based company providing a cardiac ablation system for treating cardiac arrhythmias, raised €54M in Series B funding. The round was led by existing investors Advent Life Sciences and Earlybird Health, as... |
| 27.02.2024 | Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise | - |
| 19.06.2023 | TechTour Growth Health showcases Swiss health solutions | |
| 13.01.2023 | Here are some interesting companies I met at JPM this week | Every year, MedCity News reporters receive scores of requests to meet promising companies that are hoping to solve major challenges in the U.S. healthcare system. 2023 was no different. Here are some companies I met this week in San Francis... |
| 03.11.2022 | Argá Medtech initiates First-in-Human trial | |
| 27.04.2022 | Argá Medtech Shows Promise for New Cardiac Ablation Technology at 2022 Heart Rhythm Society Annual Meeting | Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillationPreliminary feasibility study results demonstrate the company’s Coherent Sine-Burs... |
| - | Argá Medtech | “About” |